Cargando…
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
Globally, group B Streptococcus (GBS) remains the leading cause of sepsis and meningitis in young infants, with its greatest burden in the first 90 days of life. Intrapartum antibiotic prophylaxis (IAP) for women at risk of transmitting GBS to their newborns has been effective in reducing, but not e...
Autores principales: | Kobayashi, Miwako, Vekemans, Johan, Baker, Carol J., Ratner, Adam J., Le Doare, Kirsty, Schrag, Stephanie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070600/ https://www.ncbi.nlm.nih.gov/pubmed/27803803 http://dx.doi.org/10.12688/f1000research.9363.1 |
Ejemplares similares
-
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations
por: Vekemans, Johan, et al.
Publicado: (2019) -
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics
por: Vekemans, Johan, et al.
Publicado: (2019) -
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016
por: Kobayashi, Miwako, et al.
Publicado: (2019) -
Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses
por: Bianchi-Jassir, Fiorella, et al.
Publicado: (2017) -
The Digital Divide in Technologies for Autism: Feasibility Considerations for Low- and Middle-Income Countries
por: Kumm, Aubrey J., et al.
Publicado: (2021)